Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

ClinicalTrials.gov ID: NCT02641392

Public ClinicalTrials.gov record NCT02641392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ≥ 18 years of age) who participated in the core Phase 3 GED-0301-CD-002 and GED-0301-CD-003 studies and adolescent subjects (i.e., 12 to 17 years of age) who participated in the core Phase 3 GED-0301-CD-003 study. Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the subject's treatment allocation in the initial, core Phase 3 GED-0301 study. The GED-0301-CD-003 trial was not initiated; see detailed description.

Study identification

NCT ID
NCT02641392
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 25, 2016 (Actual)
Primary completion
Jan 4, 2018 (Actual)
Completion
Jan 4, 2018 (Actual)
Last update posted
Jan 29, 2019

2016 – 2018

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Medical Associates Research Group Inc. San Diego California 902123 —
Atlanta Gastroenterology Associates, LLC Atlanta Georgia 30342 —
Indiana University Indianapolis Indiana 46202 —
Health Science Research Center, LLC Pratt Kansas 67124 —
Via Christi Research a division of Via Christi Hospitals Wichita Inc Wichita Kansas 67208 —
Gastroenterology Associates LLC Baton Rouge Louisiana 70809 —
Metropolitan Gastroenterology Chevy Chase Maryland 20815 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
Gastroenterology Associates of Western Michigan PLC Wyoming Michigan 49519 —
Ehrhardt Clinical Research LLC Belton Missouri 64012 —
Columbia University Medical Center New York New York 10032 —
Trial Management Associates LLC Wilmington North Carolina 28401 —
ClinSearch LLC Chattanooga Tennessee 37421 —
Texas Clinical Research Institute LLC Arlington Texas 76012 —
Texas Digestive Disease Consultants - Dallas Dallas Texas 75231 —
Texas Digestive Disease Consultants - Southlake Flower Mound Texas 75028 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
Sagact Pllc San Antonio Texas 78229 —
San Antonio Military Medical Center San Antonio Texas 78229 —
Digestive Health Specialists of Tyler Tyler Texas 75701 —
Virginia Mason Medical Center Seattle Washington 98101 —
University of Washington School of Medicine Seattle Washington 98104 —
The Vancouver Clinic Vancouver Washington 98664-4896 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 208 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02641392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2019 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02641392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →